Kamada KMDA
NASDAQ KMDA
$7.97 +0.08 (+1.01%)
At close: Aug 20, 2026 · 11:56 AM UTC

Kamada (KMDA) Cash from Investing Activities (2013 - 2026)

Kamada's (KMDA) quarterly Cash from Investing Activities came in at -$41.2 million in Q1 2026, down 2721.78% YoY from $1.6 million in Q1 2025, and down 1384.61% on a QoQ basis from -$2.8 million in Q4 2025.

Kamada (KMDA) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Kamada (KMDA) has 14 years of Cash from Investing Activities data on file, last reported at -$41.2 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 2721.78% year-over-year to -$41.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.6 million (down 420.92% YoY) and the FY2025 annual result came in at -$9.8 million, up 8.39% from the prior year.
  • Cash from Investing Activities retreated to -$41.2 million in Q1 2026, from -$2.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$1093.0 in Q1 2023 to a low of -$41.2 million in Q1 2026.
  • A 5-year average of -$4.0 million and a median of -$2.0 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 99.79% — and 2024, when it slumped 245279.69%.
  • Tracing KMDA's Cash from Investing Activities over 5 years: stood at -$977000.0 in 2022, then plunged by 101.94% to -$2.0 million in 2023, then slumped by 48.2% to -$2.9 million in 2024, then grew by 5.1% to -$2.8 million in 2025, then tumbled by 1384.61% to -$41.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$41.2 million (Q1 2026), -$2.8 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - -
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - -
10 Kamada 459.44 Mn 429.97 Mn 22.47 Mn -2.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.54 Mn
Jun 30, 2026 -2.54 Mn
Mar 31, 2026 -41.20 Mn
Mar 31, 2026 -41.20 Mn
Dec 31, 2025 -2.78 Mn
Dec 31, 2025 -2.78 Mn
Sep 30, 2025 -3.59 Mn
Sep 30, 2025 -3.59 Mn
Jun 30, 2025 -2.01 Mn
Jun 30, 2025 -2.01 Mn
Mar 31, 2025 -1.46 Mn
Mar 31, 2025 -1.46 Mn
Dec 31, 2024 -2.92 Mn
Dec 31, 2024 -2.92 Mn
Sep 30, 2024 -2.12 Mn
Sep 30, 2024 -2.12 Mn
Jun 30, 2024 -3.01 Mn
Jun 30, 2024 -3.01 Mn
Mar 31, 2024 -2.68 Mn
Mar 31, 2024 -2.68 Mn